Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Brogan, Anita J.
153  Ergebnisse:
Personensuche X
?
1

Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-..:

Brogan, Anita J. ; Davis, Ashley E. ; Mellott, Claire E....
PharmacoEconomics.  42 (2024)  4 - p. 447-461 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Targeted preventive vaccination campaigns to reduce Ebola o..:

Bisanzio, Donal ; Davis, Ashley E. ; Talbird, Sandra E....
Vaccine.  41 (2023)  3 - p. 684-693 , 2023
Link: https://doi.org/10.1016/..
 
?
3

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk..:

Brogan, Anita J. ; Talbird, Sandra E. ; Davis, Ashley E...
PharmacoEconomics.  39 (2021)  4 - p. 421-432 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Short-term cost analysis of raltegravir versus atazanavir +..:

Brogan, Anita J. ; Davis, Ashley E. ; Goodwin, Bridgett.
PLOS ONE.  13 (2018)  8 - p. e0203293 , 2018
Link: https://doi.org/10.1371/..
 
?
5

Cost-effectiveness of Telaprevir Combination Therapy for Ch..:

Brogan, Anita J. ; Talbird, Sandra E. ; Thompson, James R....
PLoS ONE.  9 (2014)  3 - p. e90295 , 2014
Link: https://doi.org/10.1371/..
 
?
6

Cost Effectiveness of Darunavir/ritonavir Combination Antir..:

Brogan, Anita J. ; Smets, Erik ; Mauskopf, Josephine A...
PharmacoEconomics.  32 (2014)  9 - p. 903-917 , 2014
Link: https://doi.org/10.1007/..
 
?
7

982 Cost-Effectiveness of First-Line Versus Second-Line Tel..:

Brogan, Anita ; Talbird, Sandra E. ; Thompson, James R....
Gastroenterology.  142 (2012)  5 - p. S-173 , 2012
Link: https://doi.org/10.1016/..
 
?
8

Long-Term Clinical Value of Telaprevir for Treatment of Tre..:

Brogan, Anita J. ; Miller, Jeffrey D. ; Talbird, Sandra E...
Gastroenterology.  140 (2011)  5 - p. S-947 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhi..:

Brogan, Anita J. ; Talbird, Sandra E. ; Cohen, Calvin
Value in Health.  14 (2011)  5 - p. 657-664 , 2011
Link: https://doi.org/10.1016/..
 
?
10

US Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid ..:

Brogan, Anita ; Mauskopf, Josephine ; Talbird, Sandra E..
PharmacoEconomics.  28 (2010)  S1 - p. 129-146 , 2010
Link: https://doi.org/10.2165/..
 
?
11

Cost Effectiveness of Darunavir/Ritonavir in Highly Treatme..:

Mauskopf, Josephine ; Brogan, Anita ; Martin, Silas.
PharmacoEconomics.  28 (2010)  S1 - p. 83-105 , 2010
Link: https://doi.org/10.2165/..
 
?
12

Oseltamivir for Influenza Postexposure Prophylaxis:

Talbird, Sandra E. ; Brogan, Anita J. ; Winiarski, Aleksander P.
American Journal of Preventive Medicine.  37 (2009)  5 - p. 381-388 , 2009
Link: https://doi.org/10.1016/..
 
?
13

Cost-effectiveness of treating influenzalike illness with o..:

Talbird, Sandra E. ; Brogan, Anita J. ; Winiarski, Aleksander P..
American Journal of Health-System Pharmacy.  66 (2009)  5 - p. 469-480 , 2009
Link: https://doi.org/10.2146/..
 
?
14

Cost-Effectiveness Model for Neovascular Age-Related Macula..:

Javitt, Jonathan C. ; Zlateva, Gergana P. ; Earnshaw, Stephanie R....
Value in Health.  11 (2008)  4 - p. 563-574 , 2008
Link: https://doi.org/10.1111/..
 
?
15

Non-separation in the mean–lower-partial-moment portfolio o..:

Brogan, Anita J. ; Stidham Jr., Shaler
European Journal of Operational Research.  184 (2008)  2 - p. 701-710 , 2008
Link: https://doi.org/10.1016/..
 
1-15